Merck vaccine heads Ebola countermeasures

Nat Biotechnol. 2018 Jul 6;36(7):563-565. doi: 10.1038/nbt0718-563a.
No abstract available

MeSH terms

  • Africa, Western
  • Drug Industry
  • Ebola Vaccines / therapeutic use*
  • Ebolavirus / drug effects
  • Ebolavirus / pathogenicity
  • Hemorrhagic Fever, Ebola / drug therapy*
  • Hemorrhagic Fever, Ebola / epidemiology
  • Hemorrhagic Fever, Ebola / virology
  • Humans

Substances

  • Ebola Vaccines